Medical Devices Investors & VC Firms in Israel

104 firms in this list, with a median first check of $1M. 12 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
TE Tene Capital AHDBEAAL6 people	88🔒	Tel Aviv	IL	Growth	$2M	+ Add to CRM
AG Agate Medical Investments LP	88🔒	Tel-Aviv	IL	Growth–Late Stage	—	+ Add to CRM
AV Aviv Venture Capital AGSCYZ3 people	88🔒	Tel Aviv	IL	Seed–Series A	—	+ Add to CRM
EX Exigent Capital EBEDMGDM8 people	88🔒	Jerusalem	IL	Seed–Series A	—	+ Add to CRM
IS Israel Innovation Authority HBSR2 people	88🔒	Jerusalem	IL	Pre-Seed–Growth	$140K – $5M	+ Add to CRM
XE Xenia Venture Capital ATESEIMK6 people	88🔒	Tel Aviv	IL	Seed–Series A	—	+ Add to CRM
CH Champel Capital AWABGEOB6 people	88🔒	Jerusalem	IL	Seed–Late Stage	—	+ Add to CRM
SB SBI JI Innovation Advisory Ltd. HSVRVHDH6 people	88🔒	Tel Aviv-Yafo	IL	Seed–Series B	—	+ Add to CRM
SA Sanara Capital AB1 person	88🔒	Ra'anana	IL	Seed–Late Stage	—	+ Add to CRM
IN Infinity Group AGAS2 people	88🔒	Tel Aviv	IL	Growth	$1M – $10M	+ Add to CRM
PR Previz Ventures DBEA2 people	88🔒	Herzeliya	IL	Seed–Series A	—	+ Add to CRM
IS Israel Biotech Fund DSIZYCSS4 people	88🔒	Rehovot	IL	Seed–Series A	—	+ Add to CRM
TE Teuza DGMVMZAK5 people	88🔒	Haifa	IL	Pre-Seed–Late Stage	$250K – $2M	+ Add to CRM
AU Aurum Ventures MKI DJMKRMIL8 people	88🔒	Ramat Gan	IL	Seed–Late Stage	—	+ Add to CRM
EL Elron Ventures ULYS2 people	88🔒	Tel Aviv	IL	Seed–Series B	$1M – $17M	+ Add to CRM
VL VLX Ventures LCOC2 people	88🔒	Jerusalem	IL	Seed–Series A	$700K – $1M	+ Add to CRM
GV GV (Google Ventures) APBRBBCH54 people · Leads rounds	88🔒	Mountain View	US	Seed–Late Stage	$250K – $50M	+ Add to CRM
NO Norwest Venture Partners CDCSDZDN35 people · Leads rounds	88🔒	Menlo Park	US	Seed–Late Stage	$10M – $30M	+ Add to CRM
B B Capital Group BVDCESEW36 people · Leads rounds	88🔒	Manhattan Beach	US	Pre-Seed–Late Stage	$10M – $50M	+ Add to CRM
EL Elaia ACCVDVEP44 people · Follows rounds	88🔒	Paris	FR	Seed–Growth	$108K – $1.6M	+ Add to CRM
36 360 Capital AZAMCMDR30 people	88🔒	Milan	IT	Pre-Seed–Series B	$162K – $10.8M	+ Add to CRM
HE Hercules Capital, Inc. ASBPBJCB56 people	88🔒	San Mateo	US	Seed–Late Stage	$5M – $500M	+ Add to CRM
EI Eight Roads Ventures DHLCSBVB20 people	88🔒	Mumbai	IN	Seed–Late Stage	$5M – $30M	+ Add to CRM
EQ EQT Life Sciences PFADAPBJ42 people · Leads rounds	88🔒	Luxembourg	LU	Seed–Late Stage	$11M – $66M	+ Add to CRM

Tene Capital

Tel AvivGrowth$2M

AHDBEAAL6 people

Agate Medical Investments LP

Tel-AvivGrowth–Late Stage

Aviv Venture Capital

Tel AvivSeed–Series A

AGSCYZ3 people

Exigent Capital

JerusalemSeed–Series A

EBEDMGDM8 people

Israel Innovation Authority

JerusalemPre-Seed–Growth$140K – $5M

HBSR2 people

Xenia Venture Capital

Tel AvivSeed–Series A

ATESEIMK6 people

Champel Capital

JerusalemSeed–Late Stage

AWABGEOB6 people

SBI JI Innovation Advisory Ltd.

Tel Aviv-YafoSeed–Series B

HSVRVHDH6 people

Sanara Capital

Ra'ananaSeed–Late Stage

AB1 person

Infinity Group

Tel AvivGrowth$1M – $10M

AGAS2 people

Previz Ventures

HerzeliyaSeed–Series A

DBEA2 people

Israel Biotech Fund

RehovotSeed–Series A

DSIZYCSS4 people

Teuza

HaifaPre-Seed–Late Stage$250K – $2M

DGMVMZAK5 people

Aurum Ventures MKI

Ramat GanSeed–Late Stage

DJMKRMIL8 people

Elron Ventures

Tel AvivSeed–Series B$1M – $17M

ULYS2 people

VLX Ventures

JerusalemSeed–Series A$700K – $1M

LCOC2 people

GV (Google Ventures)

Mountain ViewSeed–Late Stage$250K – $50M

APBRBBCH54 people

Norwest Venture Partners

Menlo ParkSeed–Late Stage$10M – $30M

CDCSDZDN35 people

B Capital Group

Manhattan BeachPre-Seed–Late Stage$10M – $50M

BVDCESEW36 people

Elaia

ParisSeed–Growth$108K – $1.6M

ACCVDVEP44 people

360 Capital

MilanPre-Seed–Series B$162K – $10.8M

AZAMCMDR30 people

Hercules Capital, Inc.

San MateoSeed–Late Stage$5M – $500M

ASBPBJCB56 people

Eight Roads Ventures

MumbaiSeed–Late Stage$5M – $30M

DHLCSBVB20 people

EQT Life Sciences

LuxembourgSeed–Late Stage$11M – $66M

PFADAPBJ42 people

Data sourced from public filings and firms' own websites — see our methodology.